Chemical Modification of Oligo(Hexamethylene Guanidine): Synthesis of Alkylated Derivatives and Their Estimated Activity Against Mycobacterium Smegmatis
- Autores: Kedik S.A.1, Shatalov D.O.1, Askretkov A.D.1, Isaikina P.M.1, Sedishev I.P.1, Panov A.V.1, Evseeva A.S.1
-
Afiliações:
- Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University
- Edição: Volume 51, Nº 8 (2017)
- Páginas: 698-701
- Seção: Drug Synthesis Methods and Manufacturing Technology
- URL: https://bakhtiniada.ru/0091-150X/article/view/244762
- DOI: https://doi.org/10.1007/s11094-017-1677-1
- ID: 244762
Citar
Resumo
It was found that oligo(hexamethylene guanidine) (OHMG) reacted very slowly with unactivated high-molecular-mass alkyl halides (dodecyl chloride), possibly due to steric hindrance and the low nucleophilicity of the guanidine moiety. Therefore, this alkyl halide could not be used to modify OHMG under conventional conditions. Ethylation of OHMG was much more facile. However, the substitution in the derivatives was broadly scattered (under ordinary conditions and reagent ratios). It was shown simultaneously that the antibacterial activity of the alkylated derivatives was less than that of the starting OHMG hydrochloride. Benzyl chloride reacted readily with OHMG to produce derivatives with the desired degree of substitution. It was found that benzyl derivatives with 0.2 degree of substitution were more active against mycobacteria than the starting hydrochloride with the activity gradually diminishing if the degree of substitution was increased further. The increased activity may have been related to the optimum increase of OHMG hydrophobicity and/or steric structure. The rather high antibacterial activities of the benzyl derivatives against Mycobacterium smegmatis strain ATCC 607 made them promising for further development and studies of the properties of alkylated OHMG derivatives to discover more active derivatives, including against M. smegmatis. The most obvious candidates could become the methylcarboxy-substituted OHMG derivatives.
Palavras-chave
Sobre autores
S. Kedik
Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University
Email: shatalov_d@mirea.ru
Rússia, 86 Prosp. Vernadskogo, Moscow, 119571
D. Shatalov
Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University
Autor responsável pela correspondência
Email: shatalov_d@mirea.ru
Rússia, 86 Prosp. Vernadskogo, Moscow, 119571
A. Askretkov
Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University
Email: shatalov_d@mirea.ru
Rússia, 86 Prosp. Vernadskogo, Moscow, 119571
P. Isaikina
Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University
Email: shatalov_d@mirea.ru
Rússia, 86 Prosp. Vernadskogo, Moscow, 119571
I. Sedishev
Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University
Email: shatalov_d@mirea.ru
Rússia, 86 Prosp. Vernadskogo, Moscow, 119571
A. Panov
Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University
Email: shatalov_d@mirea.ru
Rússia, 86 Prosp. Vernadskogo, Moscow, 119571
A. Evseeva
Department of Biotechnology and Industrial Pharmacy, Moscow State University of Fine Chemical Technology (MITKhT), Moscow Technological University
Email: shatalov_d@mirea.ru
Rússia, 86 Prosp. Vernadskogo, Moscow, 119571
Arquivos suplementares
